$AZTA News

Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative

Azenta (AZTA) Stock Could Be Undervalued Even With Legal Scrutiny

Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)

Needham Reiterates Buy on Azenta, Maintains $37 Price Target

Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems

Why Azenta (AZTA) Stock Is Down Today

Azenta Appoints Martin Madaus Interim President, CEO; Co. Reiterates Q4 Revenue Outlook

Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue

The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call

Azenta (AZTA) Q3 2026 Earnings Call Transcript

Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed

Life Science Funding Weakness Hit Azenta’s (AZTA) Outlook

Evercore ISI Group Maintains Outperform on Azenta, Raises Price Target to $35

Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ...

Azenta Q3 Earnings Call Highlights

Needham Maintains Buy on Azenta, Raises Price Target to $37

Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript

Azenta, Inc. Q3 2026 Earnings Call Summary

Azenta, Inc. 2026 Q3 - Results - Earnings Call Presentation

Azenta (NASDAQ:AZTA) Reports Upbeat Q2 CY2026